Influence of size scale and morphology on antibacterial properties of ZnO powders hydrothemally synthesized using different surface stabilizing agents

Solvothermal synthesis of ZnO nanoparticles and anti-infection application in vivo

Zinc oxide nanoparticles (ZnONPs) have been widely studied as the bacteriostatic reagents. However, synthesis of small ZnO nanoparticles with good monodispersion and stability in aqueous solution is still a challenge. Anti-infection research of ZnONPs used as antibacterial agent in vivo is rare. In this paper, a novel, sustainable, and simple method to synthesize ZnO nanoparticles with good monodispersion in aqueous low-temperature conditions and with a small molecule agent is reported. Inhibition zone test and the minimum inhibitory concentration test were performed to examine the antibacterial activity of ZnONPs against bacteria Staphylococcus aureus and Escherichia coli in vitro. For further application in vivo, low cytotoxicity and low acute toxicity in mice of ZnO were demonstrated. Finally, 4 nm ZnONPs combined with poly(vinyl alcohol) gel was used as antibacterial agent in rodent elytritis model, and significant anti-infection effect was proven. In one word, the present research would shed new light on the designing of antibacterial materials like ZnO with promising application in disinfection.

Amino- and ionic liquid-functionalised nanocrystalline ZnO via silane anchoring – an antimicrobial synergy

The synthesis of highly antimicrobial nanocrystalline zinc oxide and its covalent modifications are presented.

Antibacterial performance of ZnO-based fillers with mesoscale structured morphology in model medical PVC composites

Three different ZnO-based antibacterial fillers having different morphologies in microscale region were prepared by the use of the microwave assisted synthesis protocol created in our laboratory with additional annealing in one case. Further, PVC composites containing 0.5-5 wt.% of ZnO based antibacterial fillers were prepared by melt mixing and characterized by scanning electron microscopy (SEM) and X-ray diffractometry (XRD). Mechanical testing showed no adverse effect on the working of polymer composites due to either of the fillers used or the applied processing conditions in comparison with the neat medical grade PVC. The surface antibacterial activity of the compounded PVC composites was assessed against Escherichia coli ATCC 8739 and Staphylococcus aureus ATCC 6538P according to ISO 22196: 2007 (E). All materials at almost all filler loading levels were efficient against both species of bacteria. The material with the most expanding morphology assuring the largest contact between filler and matrix achieved an excellent level of more than 99.9999% reduction of viable cells of E. coli in comparison to untreated PVC and performed very well against S. aureus, too. A correlation between the morphology and efficacy of the filler was observed and, as a result, a general rule was formulated which links the proneness of the microparticles to perform well against bacteria to their shape and morphology.

Amino acid-mediated synthesis of zinc oxide nanostructures and evaluation of their facet-dependent antimicrobial activity

ZnO nanostructures (ZnO-NSs) of different morphologies are synthesized with the amino acids L-alanine, L-threonine, and L-glutamine as capping agents. X-ray diffraction (XRD) shows the formation of a crystalline wurtzite phase of ZnO-NSs. The surface modification of ZnO-NSs due to the capping agents is confirmed using Fourier transform infrared (FTIR) spectroscopy. Photoluminescence spectroscopy reveals that the concentration of surface defects correlates positively with the number of polar facets in ZnO-NSs. The antimicrobial activity of the ZnO-NSs has been tested against Escherichia coli and the common pathogens Staphylococcus aureus, Klebsiella pneumoniae, and Bacillus subtilis. Culture-based methods in rich medium show up to 90% growth inhibition, depending on the ZnO-NSs. Flow cytometry analyses indicate that the reactive oxygen species (ROS) generated by ZnO-NSs contribute mostly to the antibacterial activity. Control experiments in minimal medium show that amino acids and other reducing agents in Luria-Bertani (LB) medium quench ROS, thereby decreasing the antimicrobial activity of the ZnO-NSs.

Antimicrobial activity of zinc oxide particles on five micro-organisms of the Challenge Tests related to their physicochemical properties

Zinc oxide is commonly used in pharmaceutical products to prevent or treat topical or systemic diseases owing to its antimicrobial properties, but it is scarcely used as preservative in topical formulations. The aim of this work was to investigate the antimicrobial activity of zinc oxide (ZnO) powders on the five microbial strains used for Challenge Tests in order to evaluate this inorganic compound as a preservative in topical formulation and assess relationships between the structural parameters of ZnO particles and their antimicrobial activity. For this purpose, the physicochemical characteristics of three ZnO grades were measured and their antimicrobial efficacy against the following micro-organisms - Escherichia coli; Staphylococcus aureus; Pseudomonas aeruginosa; Candida albicans; Aspergillus brasiliensis - was assessed using disc diffusion susceptibility tests and a broth dilution method. The comprehensive dataset of physicochemical characteristics and antimicrobial activities (MIC and MBC) is discussed regarding methodological issues related to the particulate nature of ZnO and structure-activity relationships. Every ZnO grade showed bactericidal and antifungal activity against the five tested micro-organisms in a concentration dependent manner. ZnO particles with smaller size, larger specific area and higher porosity exhibit higher antimicrobial activity. Such trends are related to their mechanisms of antimicrobial activity.

Anomalous antibacterial activity and dye degradation by selenium doped ZnO nanoparticles

Selenium doped ZnO nanoparticles synthesized by mechanochemical method were spherically shaped of size distribution of 10.2±3.4 nm measured by transmission electron microscopy. Diffused reflectance spectroscopy revealed increase in the band gap, ranging between 3.47 eV and 3.63 eV due to Se doping in ZnO nanoparticles. The antibacterial activity of pristine and Se doped ZnO nanoparticles was attributed to ROS (reactive oxygen species) generation in culture media confirmed by TBARS assay. Compared to complete inhibition of growth by 0.45 mg/mL of pristine ZnO nanoparticles, the batches of 0.45 mg/mL of selenium doped ZnO nanoparticles exhibited only 51% inhibition of growth of Escherichia coli. The reduced antibacterial activity of selenium doped ZnO nanoparticles was attributed to two opposing factors, e.g., ROS generation for inhibition of growth, countered by sustaining growth of E. coli due to availability of Se micronutrients in culture media, confirmed by inductively coupled plasma mass spectrometer measurement. Higher ROS generation by selenium doped ZnO nanoparticles was attributed to creation of oxygen vacancies, confirmed from green emission peak observed at 565 nm. The impact of higher ROS generation by selenium doped ZnO nanoparticles was evident from enhanced photocatalytic degradation of trypan blue dye, than pristine ZnO nanoparticles.